Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents.

导出 LinkOut

翻译打印收藏纠错

第一作者： Eriko,Yasutomi

第一单位： Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

作者： Eriko,Yasutomi ^[1] ; Sakiko,Hiraoka ^[1] ; Shumpei,Yamamoto ^[1] ; Shohei,Oka ^[1] ; Mami,Hirai ^[1] ; Yasushi,Yamasaki ^[1] ; Toshihiro,Inokuchi ^[1] ; Hideaki,Kinugasa ^[1] ; Masahiro,Takahara ^[1] ; Keita,Harada ^[1] ; Jun,Kato ^[2] ; Hiroyuki,Okada ^[1]

作者单位： Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan. ^[1] Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba 260-0856, Japan. ^[2]

关键词 mesalazine salicylates sulfasalazine ulcerative colitis

DOI 10.3390/jcm8122109

PMID 31810227

发布时间 2024-03-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览3

Journal of clinical medicine

2019年8卷12期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents.

Journal of clinical medicine

相似文献

Journal of clinical medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents.

Journal of clinical medicine

相似文献

Journal of clinical medicine

相关期刊

检索历史清除